Understanding the Archive and Foreseeing the Future

2025.01.23
The progress of chromatography since the late 1970s has been remarkable. In the field of protein research, techniques for isolating target proteins advanced around Sephadex media, and the introduction of… 黒澤伸行

Issue No. 7: Baseline Research and Biomarker Exploration

2024.07.18
It is believed that it will take at least 10 years for the drugs currently under development to begin practical use. By then, the overall healthcare system surrounding drugs is expected to differ significantl… 黒澤伸行

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

2024.07.05
This series is based on the recognition that “drug development is entering a major t… 黒澤伸行

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

2024.07.03
This series is based on the recognition that “drug development is entering a major turning point,” with its main theme… 黒澤伸行

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

2024.07.03
In this series, we have been reviewing the drastic changes in the research and development environment for drug creation since around 2010. In the … 黒澤伸行

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

2024.06.29
This series begins with the recognition that drug development is entering a significant turning point. The main theme is to anticipate the next era from th… 黒澤伸行

Issue No. 2: From Drug Discovery and Development to Precision Medicine

2024.06.21
Recently, three acquisition reports in the pharmaceutical industry have drawn significant attention: Takeda Pharmaceutical’s acqui… 黒澤伸行

Issue No. 1: Drug Development at a Crisis or Turning Point

2024.06.14
The author has no prior experience working in a pharmaceutical company nor direct involvement in drug resea… 黒澤伸行

Session 6: What Is True Marketing?

2025.01.09
【Hisashi Iwase】 For someone like me in my 40s, caught up in the whirlwind of dramatic corporate mergers and acquisitions, these experiences became invaluable to my social and professional life thereaft… 黒澤伸行

Session 5: The Beginning of a New Survival Era

2025.01.15
【Hisashi Iwase】 In June 2007, PerSeptive Biosystems Japan Corporation received the “No. 1 Sales Award.” A total of 14 members, including all sales representatives and marketing team members, were invited to the U.S. head.… 黒澤伸行

Columns

Understanding the Archive and Foreseeing the Future

Issue No. 7: Baseline Research and Biomarker Exploration

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

Issue No. 2: From Drug Discovery and Development to Precision Medicine

Issue No. 1: Drug Development at a Crisis or Turning Point

Session 6: What Is True Marketing?

Session 5: The Beginning of a New Survival Era

Recent Posts

Event Schedule

calender

Popular Posts

Columns

Understanding the Archive and Foreseeing the Future

Issue No. 7: Baseline Research and Biomarker Exploration

Issue No. 6: Expectations for Drug Discovery and Health Research Using Simple Model Organisms – From the Perspective of ICT Utilization

Issue No. 5: Urgent Need for Building Co-Creation Platforms and Developing ICT Talent

Issue No. 4: How to Navigate the Second Internet Revolution and the New Wave of Artificial Intelligence?

Issue No. 3: Can the ‘Pipeline’ of Drug Development Be Reconsidered?

Issue No. 2: From Drug Discovery and Development to Precision Medicine

Issue No. 1: Drug Development at a Crisis or Turning Point

Session 6: What Is True Marketing?

Session 5: The Beginning of a New Survival Era

Recent Posts

Tag Cloud

Event Schedule

calender

Popular Posts